X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pharmacotherapy (127) 127
humans (103) 103
index medicus (99) 99
pharmacology & pharmacy (96) 96
medicine & public health (95) 95
pharmacology/toxicology (79) 79
internal medicine (77) 77
toxicology (65) 65
drug therapy (43) 43
dosage and administration (38) 38
pharmacokinetics (38) 38
care and treatment (37) 37
pharmacy (34) 34
research (34) 34
double-blind (25) 25
clinical trials as topic (24) 24
randomized controlled trials as topic (23) 23
therapeutic use (23) 23
treatment outcome (23) 23
pharmacodynamics (21) 21
adult (18) 18
health aspects (17) 17
risk factors (17) 17
adis drug evaluations (16) 16
clinical trials (16) 16
female (16) 16
complications and side effects (15) 15
drug dosages (15) 15
efficacy (15) 15
animals (14) 14
management (14) 14
psychiatry (14) 14
analysis (13) 13
cost-effectiveness (13) 13
tolerability (13) 13
usage (13) 13
adis-drug-evaluations (12) 12
clinical trials, phase iii as topic (12) 12
clinical neurology (11) 11
neurology (11) 11
neurosciences (11) 11
safety (11) 11
adis drug profiles (10) 10
antineoplastic agents - therapeutic use (10) 10
psychopharmacology (10) 10
quality of life (10) 10
therapy (10) 10
trial (10) 10
child (9) 9
dose-response relationship, drug (9) 9
drug combinations (9) 9
patients (9) 9
prevention (9) 9
studies (9) 9
adis-drug-profiles (8) 8
antibodies (8) 8
drug administration schedule (8) 8
drug approval (8) 8
male (8) 8
pharmacoeconomics (8) 8
quality-of-life (8) 8
adolescent (7) 7
antibodies, monoclonal - therapeutic use (7) 7
biomedicine (7) 7
cancer research (7) 7
chemotherapy (7) 7
cost-benefit analysis (7) 7
immunology (7) 7
molecular medicine (7) 7
patient outcomes (7) 7
placebo-controlled trial (7) 7
psoriasis (7) 7
antineoplastic agents - adverse effects (6) 6
area under curve (6) 6
children (6) 6
delayed-action preparations (6) 6
development and progression (6) 6
diagnosis (6) 6
oncology (6) 6
adults (5) 5
antibodies, monoclonal - adverse effects (5) 5
antibodies, monoclonal, humanized - therapeutic use (5) 5
cancer (5) 5
clinical trials as topic - methods (5) 5
drug therapy, combination (5) 5
drugs (5) 5
economics, pharmaceutical (5) 5
fluticasone (5) 5
geriatrics & gerontology (5) 5
geriatrics/gerontology (5) 5
in-vitro (5) 5
monoclonal antibodies (5) 5
multiple sclerosis (5) 5
neoplasm metastasis (5) 5
pharmaceutical industry (5) 5
randomized controlled-trial (5) 5
severity of illness index (5) 5
trastuzumab (5) 5
administration, oral (4) 4
aged (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Drugs, ISSN 0012-6667, 05/2015, Volume 75, Issue 7, p. 809
  Tiotropium bromide (Spiriva®) solution for inhalation via the Respimat® SoftMist(TM) inhaler is a longacting anticholinergic agent approved in the EU for the... 
Journal Article
Drugs, ISSN 0012-6667, 2015, Volume 75, Issue 2, p. 241
Journal Article
Drugs, ISSN 0012-6667, 2/2015, Volume 75, Issue 2, pp. 241 - 241
Journal Article
Drugs, ISSN 0012-6667, 5/2013, Volume 73, Issue 6, pp. 563 - 574
Pasireotide (Signifor®) is a new subcutaneous somatostatin analogue that acts via somatostatin receptors to inhibit the secretion of corticotropin from the... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology
Journal Article
Clinical Drug Investigation, ISSN 1173-2563, 05/2015, Volume 35, Issue 5, p. 335
Journal Article
Drugs, ISSN 0012-6667, 07/2012, Volume 72, Issue 11, p. 1559
  Docetaxel (Taxotere®) is a well established anti-mitotic chemotherapy agent. Among other therapeutic indications, docetaxel plus prednisone is indicated for... 
Journal Article
Drugs, ISSN 0012-6667, 03/2012, Volume 72, Issue 4, p. 543
  Indacaterol inhalation powder (Onbrez® Breezhaler®) is a long-acting, selective β2-adrenoceptor agonist that is indicated for the maintenance bronchodilator... 
Journal Article
Drugs & Therapy Perspectives, ISSN 1172-0360, 1/2016, Volume 32, Issue 1, pp. 6 - 12
Tolvaptan (Samsca®) is an orally administered highly selective vasopressin V2 receptor antagonist that increases the clearance of electrolyte-free water,... 
Pharmacotherapy | Pharmacy | Clinical trials | Care and treatment | Usage | Hyponatremia
Journal Article
Drugs, ISSN 0012-6667, 12/2011, Volume 71, Issue 17, p. 2327
  Eculizumab is a humanized monoclonal antibody indicated for the treatment of paroxysmal nocturnal haemoglobinuria (PNH). It binds specifically and with high... 
Journal Article
Drugs & Therapy Perspectives, ISSN 1172-0360, 9/2015, Volume 31, Issue 9, pp. 296 - 301
CT-P13 (Remsima™; Inflectra™) is an infliximab biosimilar approved in the EU for use in all indications for which reference infliximab is approved, including... 
Pharmacotherapy | Pharmacy | Care and treatment | Dosage and administration | Crohn's disease | Infliximab | Analysis | Medical care, Cost of
Journal Article
PharmacoEconomics, ISSN 1170-7690, 09/2012, Volume 30, Issue 9, p. 841
  This article provides an overview of the clinical profile of oral dabigatran etexilate (Pradaxa®, Pradax(TM)) [hereafter referred to as dabigatran] when used... 
Studies | Cardiac arrhythmia | Health care expenditures | Economic theory | Research & development--R&D | Analysis | Pharmaceuticals
Journal Article
CNS Drugs, ISSN 1172-7047, 01/2016, Volume 30, Issue 1, pp. 79 - 90
  A new extended-release (ER) capsule formulation of carbidopa/levodopa (Rytary®, Numient(TM), IPX066) is available for the treatment of Parkinson's disease... 
Dopamine | Funding | Parkinsons disease | Conflicts of interest | FDA approval | Bioavailability | Metabolism | Clinical outcomes
Journal Article
Drugs and Therapy Perspectives, ISSN 1172-0360, 2015, Volume 31, Issue 4, pp. 112 - 117
Journal Article
Paediatric drugs, 02/2016, Volume 18, Issue 1, p. 75
The intranasal formulation of zolmitriptan, a selective serotonin 5-HT1B/1D agonist, was recently approved by the US Food and Drug Administration for the... 
Serotonin Receptor Agonists - therapeutic use | United States | Humans | Nasal Sprays | Oxazolidinones - administration & dosage | Administration, Intranasal | Child | Migraine Disorders - drug therapy | Serotonin Receptor Agonists - administration & dosage | Tryptamines - administration & dosage
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.